These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Why do ulcers heal with sucralfate? Lam SK Scand J Gastroenterol Suppl; 1990; 173():6-16. PubMed ID: 2190306 [TBL] [Abstract][Full Text] [Related]
25. Comparison of sucralfate and cimetidine in the treatment of duodenal and gastric ulcers. A multicenter study. Pop P; Nikkels RE; Thys O; Dorrestein GC Scand J Gastroenterol Suppl; 1983; 83():43-7. PubMed ID: 6356320 [TBL] [Abstract][Full Text] [Related]
26. Role of protective drugs in the prevention of ulcer relapse. Ota S; Terano A J Gastroenterol; 1994 Jul; 29 Suppl 7():139-40. PubMed ID: 7921147 [TBL] [Abstract][Full Text] [Related]
27. The drug treatment of duodenal ulcer: physiological considerations in the choice of therapy. Jones DB; Hunt RH Aust N Z J Med; 1986 Apr; 16(2):263-7. PubMed ID: 2875708 [No Abstract] [Full Text] [Related]
28. Newer drugs in the treatment of peptic ulcer. Tandon BN Trop Gastroenterol; 1985; 6(4):188-92. PubMed ID: 3913076 [No Abstract] [Full Text] [Related]
29. Update in treatment of peptic ulcer disease. Schubert TT Mo Med; 1984 Nov; 81(11):723-7. PubMed ID: 6095013 [No Abstract] [Full Text] [Related]
30. Pharmacology of the treatment of peptic ulcer disease. Bertaccini G; Coruzzi G Dig Dis Sci; 1985 Nov; 30(11 Suppl):43S-51S. PubMed ID: 2865092 [TBL] [Abstract][Full Text] [Related]
31. Bismuth: effects on gastritis and peptic ulcer. Rokkas T; Sladen GE Scand J Gastroenterol Suppl; 1988; 142():82-6. PubMed ID: 3047853 [TBL] [Abstract][Full Text] [Related]
32. [Treatment of stomach ulcer (review)]. Berndt H; Otto R Z Arztl Fortbild (Jena); 1982 Aug; 76(16):705-10. PubMed ID: 6897314 [No Abstract] [Full Text] [Related]
33. [Maintenance therapy of ulcer disease. Comparative multicenter study of sucralfate, cimetidine and a placebo]. Jean F; Bonnefond A; Gislon J; Kloeti G; Libeskind M; Petite JP; Rautureau J; Roberti A; Zeitoun P Rev Med Interne; 1985 Jun; 6(3):321-6. PubMed ID: 3901172 [TBL] [Abstract][Full Text] [Related]
34. Implications of sucralfate-induced ulcer healing and relapse. Lam SK Am J Med; 1989 Jun; 86(6A):122-6. PubMed ID: 2660554 [TBL] [Abstract][Full Text] [Related]
35. New perspectives in the treatment of peptic ulcer and related conditions. Milton-Thompson GJ; Misiewicz JJ Trans Med Soc Lond; 1977-1978; 94():46-57. PubMed ID: 317762 [No Abstract] [Full Text] [Related]
36. Present and future treatment of peptic ulcer and potential role of DE-NOL. Scand J Gastroenterol Suppl; 1982; 80():49-57. PubMed ID: 6761852 [No Abstract] [Full Text] [Related]
37. Relapse rates in duodenal ulcer patients formerly treated with bismuth subcitrate or maintained with cimetidine. Bianchi Porro G; Lazzaroni M; Petrillo M; De Nicola C Lancet; 1984 Sep; 2(8404):698. PubMed ID: 6147723 [No Abstract] [Full Text] [Related]
38. [Antisecretory and mucosa-protecting drugs in the acute care of peptic ulcer. Review of action principles, healing rates and side effects of approved ulcer drugs and drugs under clinical trial]. Simon B; Müller P; Dammann HG Fortschr Med; 1984 Jul; 102(25-26):683-7. PubMed ID: 6147304 [TBL] [Abstract][Full Text] [Related]
39. Stress ulcers--prevention of gastrointestinal bleeding in critical care units. Bank S Med J Aust; 1985 Feb; 142 Spec No():S17-20. PubMed ID: 2869398 [No Abstract] [Full Text] [Related]
40. Likelihood of relapse of duodenal ulcer after initial treatment with cimetidine or colloidal bismuth subcitrate. Miller JP; Hollanders D; Ravenscroft MM; Tweedle DE; Martin DF Scand J Gastroenterol Suppl; 1982; 80():39-42. PubMed ID: 6761851 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]